Alkermes plc. Payments of Debt Issuance Costs
Alkermes plc. (ALKS) reported Payments of Debt Issuance Costs of $2.98 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2026-07-28
- Alkermes plc. payments of debt issuance costs for the quarter ending 2026-06-30 was $1.37M.
- Alkermes plc. payments of debt issuance costs for the quarter ending 2026-03-31 was $1.61M.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 6 month |
|---|---|---|
| 2026-06-30 | $1.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-28 | $2.98M 10-Q · filed 2026-07-28 |
| 2026-03-31 | $1.61M 10-Q · filed 2026-05-05 | |
| 2025-06-30 | $0.00 10-Q · filed 2026-07-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |